Cargando…

Small Cell Carcinoma of Ovary, Hypercalcemic Type (Malignant Rhabdoid Tumor of Ovary) with Loss of SMARCA4 (BRG1) Expression: Report of Two Cases

Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) / malignant rhabdoid tumor of the ovary (MRTO) is a rare tumor affecting young women. It is frequently misdiagnosed due to overlapping morphological and immunohistochemical features with many other ovarian tumors. The prognosis of the tu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sahay, Ayushi, Kante, Katha, Menon, Santosh, Ghosh, Jaya, Kerkar, Rajendra A., Deodhar, Kedar K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Federation of Turkish Pathology Societies 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510597/ https://www.ncbi.nlm.nih.gov/pubmed/32149361 http://dx.doi.org/10.5146/tjpath.2020.01477

Ejemplares similares

Small Cell Carcinoma of the Ovary (Hypercalcemic Type): Malignant Rhabdoid Tumor
por: Kascak, Peter, et al.
Publicado: (2016)

Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type
por: Jelinic, Petar, et al.
Publicado: (2016)

Loss of the tumor suppressor SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)
por: Ramos, Pilar, et al.
Publicado: (2014)

Re-expression of SMARCA4/BRG1 in small cell carcinoma of ovary, hypercalcemic type (SCCOHT) promotes an epithelial-like gene signature through an AP-1-dependent mechanism
por: Orlando, Krystal Ann, et al.
Publicado: (2020)

Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond SMARCA4 Mutations: A Comprehensive Genomic Analysis
por: Auguste, Aurélie, et al.
Publicado: (2020)

Small cell carcinoma of the ovary hypercalcemic type (SCCOHT): A review and novel case with dual germline SMARCA4 and BRCA2 mutations
por: Sanders, Brooke E., et al.
Publicado: (2022)

Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type
por: Karnezis, Anthony N, et al.
Publicado: (2015)

Molecular analyses reveal close similarities between small cell carcinoma of the ovary, hypercalcemic type and atypical teratoid/rhabdoid tumor
por: Fahiminiya, Somayyeh, et al.
Publicado: (2015)

CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary
por: Xue, Yibo, et al.
Publicado: (2019)

Small Cell Carcinoma of the Ovary of Hypercalcemic Type: A Case Report
por: Zaied, S., et al.
Publicado: (2012)

Prophylactic oophorectomy for hereditary small cell carcinoma of the ovary, hypercalcemic type
por: Berchuck, Andrew, et al.
Publicado: (2015)

Molecular Characterization of a Patient's Small Cell Carcinoma of the Ovary of the Hypercalcemic Type
por: Stephens, Bret, et al.
Publicado: (2012)

Multimodal molecular analysis of an atypical small cell carcinoma of the ovary, hypercalcemic type
por: David, Marjorie P., et al.
Publicado: (2018)

Case Report of Small Cell Carcinoma of the Ovary, Hypercalcemic Type (Ovarian Rhabdoid Tumor) with SMARCB1 Mutation: A Literature Review of a Rare and Aggressive Condition
por: Simões, Maria Fernanda Evangelista, et al.
Publicado: (2022)

Germline SMARCA4 mutations in patients with ovarian small cell carcinoma of hypercalcemic type
por: Moes-Sosnowska, Joanna, et al.
Publicado: (2015)

The dilemma of early preventive oophorectomy in familial small cell carcinoma of the ovary of hypercalcemic type
por: Pejovic, Tanja, et al.
Publicado: (2019)

SMARCB1 (INI1) retained but SMARCA4 (BRG1) negative atypical teratoid/rhabdoid tumor arising at the bilateral cerebellopontine angles: a case report
por: Mitsui, Nobuyuki, et al.
Publicado: (2021)

Cellular Expression of Smarca4 (Brg1)-regulated Genes in Zebrafish Retinas
por: Hensley, Monica R, et al.
Publicado: (2011)

TTF1-positive SMARCA4/BRG1 deficient lung adenocarcinoma
por: Mehta, Anurag, et al.
Publicado: (2022)

The hereditary nature of small cell carcinoma of the ovary, hypercalcemic type: two new familial cases
por: Witkowski, Leora, et al.
Publicado: (2016)

Immune-Active Microenvironment in Small Cell Carcinoma of the Ovary, Hypercalcemic Type: Rationale for Immune Checkpoint Blockade
por: Jelinic, Petar, et al.
Publicado: (2018)

SMARCA2/BRM-Deficient Undifferentiated/Rhabdoid Carcinoma of Unknown Primary Site
por: Tono, Yasutaka, et al.
Publicado: (2022)

Primary rhabdoid tumor of the ovary: When large cells become small cells
por: Rabinovich, Alex, et al.
Publicado: (2015)

SWI/SNF chromatin remodeling subunit Smarca4/BRG1 is essential for female fertility
por: Abedini, Atefeh, et al.
Publicado: (2022)

Case Report: SMARCA4 (BRG1)-deficient undifferentiated carcinoma of gallbladder with genetic analysis
por: Meng, Xiangpeng, et al.
Publicado: (2023)

Small cell carcinoma of the ovary hypercalcemic type (SCCOHT): A rare case after in vitro fertilization (IVF)
por: Ghazi, Ahmed, et al.
Publicado: (2017)

Risk reduction for small cell cancer of the ovary, hypercalcemic type in prepubertal patient: A clinical and bioethical perspective
por: Vu, John A., et al.
Publicado: (2023)

Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT): Patient Characteristics, Treatment, and Outcome—A Systematic Review
por: Wens, Francis S. P. L., et al.
Publicado: (2023)

An In-Depth Look at Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT): Clinical Implications from Recent Molecular Findings
por: Lu, Bingjian, et al.
Publicado: (2019)

Correction to: SWI/SNF chromatin remodeling subunit Smarca4/BRG1 is essential for female fertility
Publicado: (2023)

The role of chromatin remodeler SMARCA4/BRG1 in brain cancers: a potential therapeutic target
por: Navickas, Sophie M., et al.
Publicado: (2023)

Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma
por: Schallenberg, Simon, et al.
Publicado: (2020)

Successful treatment of a stage IIIC small-cell carcinoma of the ovary hypercalcemic subtype using multi-modality therapeutic approach
por: Qin, Qian, et al.
Publicado: (2018)

Malignancies of the Ovary, Uterus and Cervix
por: Hunter, R.
Publicado: (1980)

Successful pregnancy following chemotherapy in a survivor of small cell carcinoma of the ovary, hypercalcemic type (SCCOHT): A case report and review of literature()
por: Phoolcharoen, Natacha, et al.
Publicado: (2020)

In Vitro Effects of Mitochondria-Targeted Antioxidants in a Small-Cell Carcinoma of the Ovary of Hypercalcemic Type and in Type 1 and Type 2 Endometrial Cancer
por: Castelôa, Mariana, et al.
Publicado: (2022)

Case Report: A Durable Response to Camrelizumab and Apatinib Combination Therapy in a Heavily Treated Small Cell Carcinoma of the Ovary, Hypercalcemic Type
por: Li, Guiling, et al.
Publicado: (2022)

Consensus meeting and update on existing guidelines for management of cervical cancer with special emphasis on the practice in developing countries, including India: The expert panel at the 8(th) annual women's cancer initiative Tata Memorial Hospital Conference 2010-11
por: Mahantshetty, Umesh, et al.
Publicado: (2012)

Pregnancy in polycystic ovary syndrome
por: Kamalanathan, Sadishkumar, et al.
Publicado: (2013)

Hypercalcemic Disorders in Children
por: Stokes, Victoria J, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_sf0d13uoq6tgu3v0m1nq65jliv